Palatin Technologies, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
CRANBURY, N.J., March 9, 2011 - Palatin Technologies, Inc. (NYSE Amex: PTN) announced that it will be presenting at the ROTH 23rd Annual OC Growth Stock Conference on Tuesday, March 15, 2011, at 12:00 p.m. Pacific Time. The conference will be held at the Ritz Carlton Laguna Niguel in Dana Point, CA.
Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs. A live audio broadcast will be available on the "Investors" section of Palatin's website at www.palatin.com. The live audio broadcast will be available through March 22, 2011.
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin Technologies' website at www.palatin.com.
SOURCE Palatin Technologies, Inc.
CONTACT: Palatin Technologies Investor Inquiries: Stephen T. Wills, CPA, MST, EVP-Operations, Chief Financial Officer, +1-609-495-2200, info@palatin.com, Palatin Technologies Media Inquiries: Carney Noensie, Burns McClellan, Vice President, Investor Relations, +1-212-213-0006, cnoensie@burnsmc.com
Web Site: www.palatin.com
